...of America (PhRMA), Washington, D.C. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Petah Tikva, Israel University of Georgia Research Foundation...

...zoster virus (VZV) infection. Next, Inhibitex exclusively licensed a preclinical HIV integrase inhibitor from the University of Georgia Research Foundation...
...NYSE:MRK), Whitehouse Station, N.J. Pharmasset Inc. (NASDAQ:VRUS), Princeton, N.J. University of Cardiff , Cardiff, U.K. University of Georgia Research Foundation...

...foundation is eligible for royalties. Terms were not disclosed. VaxyGen Holdings LLC , location undisclosed University of Georgia Research Foundation...

...antiviral agent. Further terms were not disclosed. Bukwang Pharmaceutical Co. Ltd. , Seoul, South Korea University of Georgia Research Foundation...

...kit in early 1Q09. Financial terms were not disclosed. ArunA Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...

...three years of R&D funding, and potential milestones and royalties. Inhibitex Inc. (INHX), Atlanta, Ga. University of Georgia Research Foundation...

...undisclosed third-party distribution partner. Financial terms were not disclosed. Aruna Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...

...Euroscreen Products' exclusive worldwide license to AequoScreen aequorin-based luminescent cellular assay technology, granted by the University of Georgia Research Foundation...

...Sciences Inc. (GILD, Foster City, Calif.) returned rights to the compound to Emory and the University of Georgia Research Foundation...

...is in Phase II testing to treat HIV and HBV, from Emory University and the University of Georgia Research Foundation...